| Dr Martina Trinese Caldwell, MD | |
|
1500 E. Medical Center Drive, B1-380 Tc, Ann Arbor, MI 48109-5305 | |
| (734) 763-7919 | |
| (734) 763-9298 |
| Full Name | Dr Martina Trinese Caldwell |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 14 Years |
| Location | 1500 E. Medical Center Drive, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659690758 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301096683 (Michigan) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | 4301096683 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus surgery, announced that it has received clearance from the U.S. Food and Drug Administration to expand indications of the Lapiplasty® 3D Bunion Correction™ System to treat pediatric patients greater than 12 years of age.
The Ontario Hospital Association (OHA) is pleased to announce that it has been recognized as one of Greater Toronto's Top 90 Employers for 2010.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
› Verified 9 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134144801 PECOS PAC ID: 0547178311 Enrollment ID: O20031105000139 |
News Archive
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus surgery, announced that it has received clearance from the U.S. Food and Drug Administration to expand indications of the Lapiplasty® 3D Bunion Correction™ System to treat pediatric patients greater than 12 years of age.
The Ontario Hospital Association (OHA) is pleased to announce that it has been recognized as one of Greater Toronto's Top 90 Employers for 2010.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Martina Trinese Caldwell, MD 1500 E. Medical Center Drive, B1-380 Tc, Ann Arbor, MI 48109-5305 Ph: (734) 763-7919 | Dr Martina Trinese Caldwell, MD 1500 E. Medical Center Drive, B1-380 Tc, Ann Arbor, MI 48109-5305 Ph: (734) 763-7919 |
News Archive
Perrigo Company plc today announced that it has received final approval from the U.S. Food & Drug Administration for its abbreviated new drug application for repaglinide tablets 1 mg and 2 mg, the generic equivalent to Prandin Tablets (repaglinide tablets) and has commenced shipment of product. Perrigo previously launched the 0.5 mg strength in 2013.
Building off the success of its Continuing Umbrella for Research Education Program that encourages underrepresented minority undergraduate and high school students to pursue careers in healthcare, the Cancer Institute of New Jersey is offering a related program focusing on clinical research.
Treace Medical Concepts, Inc., a medical device company focused on advancing the standard of care for hallux valgus surgery, announced that it has received clearance from the U.S. Food and Drug Administration to expand indications of the Lapiplasty® 3D Bunion Correction™ System to treat pediatric patients greater than 12 years of age.
The Ontario Hospital Association (OHA) is pleased to announce that it has been recognized as one of Greater Toronto's Top 90 Employers for 2010.
The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.
› Verified 9 days ago
Timothy Patrick Visclosky, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Phillip Alton Scott, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Kylee E Phillips, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Drive, B1 Floor University Hospital Recp Emergency, Ann Arbor, MI 48109 Phone: 734-936-6666 | |
Abhinav Nafday, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Drive, Ann Arbor, MI 48109 Phone: 734-763-7919 Fax: 734-763-9298 | |
John C Baselle, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Green Rd, Suite 100, Ann Arbor, MI 48105 Phone: 734-995-3764 Fax: 208-475-9028 | |
Robert W Neumar, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Scott Richard Ferguson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, B1-380 Tc, Ann Arbor, MI 48109 Phone: 734-763-7919 Fax: 734-763-9298 |